Home / About Novasep / Media & Events / Press releases

Press releases

REFINANCING – LAUNCH OF AN EXCHANGE OFFER AND CONSENT SOLICITATION

26 Sep 2016

Lyon, France, September 26, 2016


Novasep and Triclinic Labs enter a strategic alliance for solid-state chemistry services

Novasep and Triclinic Labs enter a strategic alliance for solid-state chemistry services

14 Sep 2016

Partnership will enable Novasep to offer early-stage solid-state chemistry services in North America


NOVASEP named Import/Export National Champion for France in The European Business Awards 2016/17

NOVASEP named Import/Export National Champion for France in The European Business Awards 2016/17

08 Sep 2016

Novasep recognised in Europe’s largest business competition as a leading exporter of industrial equipment and manufacturing services


Novasep appoints Dr. François D’Hooge as bioconjugation unit manager

06 Sep 2016

Dr. D’Hooge, an expert in antibody drug conjugation biochemistry, will take charge of Novasep’s new production unit


Demonstration project started for the conversion of woody biomass to chemicals

Demonstration project started for the conversion of woody biomass to chemicals

01 Sep 2016

By a consortium of 14 European companies using EU funding under the Horizon 2020 program


Novasep opens kilo lab extension at US facility

02 Jun 2016

Production of kilogram scale batches of synthetic molecules for early stage development now available to US customers


Novasep and GTP Technology join forces to ease production of mAbs and recombinant proteins

21 Mar 2016

Partnership offers biotech firms full CDMO services at all development stages from gene to end product


Novasep presents the second successful year of its ‘back to basics’ strategy and preliminary 2015 financial results

Novasep presents the second successful year of its ‘back to basics’ strategy and preliminary 2015 financial results

02 Mar 2016

- Solid 7% sales growth in 2015 (€266m)
- Strong EBITDA growth with a 15% increase to €31m


Novasep adds synthesis and kilo lab extensions to US facility

28 Jan 2016

Enhanced capabilities bring Novasep’s unique range of specialized drug development technologies within easier reach of North American customers


Novasep and Advanced Biotherapeutics Consulting team up on Adeno-Associated Virus (AAV) vectors

Novasep and Advanced Biotherapeutics Consulting team up on Adeno-Associated Virus (AAV) vectors

13 Jan 2016

Strategic partnership creates a world leading CDMO offer to supply AAV-based viral vectors, an increasingly attractive therapeutic platform for gene therapy


You can stay on this page and select more documents or you can directly download the brochure(s) you selected